Advent Health
Also known as: AdventHealth | Advent Health | AdventHealth Kissimmee | AdventHealth Orlando | AdventHealth Translational Research Institute | Florida Hospital | Florida Hospital Cancer Institute | Florida Hospital Celebration Health | Florida Hospital - Center for Interventional Endoscopy | Florida Hospital for Children | Florida Hospital for Children - Orlando | Florida Hospital Orlando | Florida Hospital, Orlando, FL. | Florida Hospital Tampa | Florida Hospital Tampa Bay Division | Florida Hospital Translational Research Institute for Metabolism and Diabetes | Florida Hospital Transplant Center | Senior Investigator, Translational Research Institute, AdventHealth
Highest phase reached
Phase 4
First clinical trial
Aug 1, 2007Last known activity
Nov 30, 2025
Timeline
1970s
- Jun 1, 1973
Advent Health— Founded
Drugs by trial phase (56 distinct, 41 trials)
Phase 4 (23 own, 0 via acquisition)
Phase 3 (2 own, 0 via acquisition)
Phase 2 (14 own, 0 via acquisition)
Phase 1 (9 own, 0 via acquisition)
Other trials (8 own, 0 via acquisition)
Indications
Studied for
- Adenoma
- Brain Neoplasms
- Breast Neoplasms
- Bronchopulmonary Dysplasia
- Carcinoma
- Carcinoma, Ovarian Epithelial
- Cardiovascular Diseases
- Cerebral Infarction
- Cerebrovascular Disorders
- Deafness
- Embolism
- Esophageal Stenosis
- Fallopian Tube Neoplasms
- Hearing Loss
- Hearing Loss, Sensorineural
- Hypertension
- Hypertension, Pulmonary
- Ischemia
- Multiple Myeloma
- Muscle Hypotonia
- Neoplasms, Plasma Cell
- Ovarian Neoplasms
- Peritoneal Neoplasms
- Postoperative Pain
- Pulmonary Embolism
- Spinal Cord Injuries
- Stroke
- Thromboembolism
- Wounds and Injuries
Recent trials (50)
- NCT04374370Lead sponsorN/A—
- NCT04374370Overall official - principal investigatorN/A—
- NCT07185945CollaboratorPhase 2Nov 30, 2025
- NCT07052942CollaboratorPhase 4Aug 1, 2025
- NCT06631521Lead sponsorPhase 1Oct 22, 2024
- NCT06617481Lead sponsorPhase 2Sep 20, 2024
- NCT05574504Lead sponsorPhase 2Jan 31, 2023
- NCT05574504Reponsible party - principal investigatorPhase 2Jan 31, 2023
- NCT05363644Overall official - principal investigatorPhase 3May 31, 2022
- NCT05363644Reponsible party - principal investigatorPhase 3May 31, 2022
- NCT05363644Lead sponsorPhase 3May 31, 2022
- NCT05264922Lead sponsorPhase 2Jan 10, 2022
- NCT05264922Overall official - principal investigatorPhase 2Jan 10, 2022
- NCT04999488Overall official - principal investigatorEarly Phase 1Oct 31, 2021
- NCT04905446Overall official - principal investigatorN/ASep 10, 2021
Details
- Founded
- Altamonte Springs, FL, US Jun 1, 1973
- Last known activity
- Nov 30, 2025